Published in Am J Pathol on February 01, 1998
Astrocytes: biology and pathology. Acta Neuropathol (2009) 8.43
GFAP and its role in Alexander disease. Exp Cell Res (2007) 1.66
Autophagy induced by Alexander disease-mutant GFAP accumulation is regulated by p38/MAPK and mTOR signaling pathways. Hum Mol Genet (2008) 1.63
Allele-specific nuclear positioning of the monoallelically expressed astrocyte marker GFAP. Genes Dev (2008) 1.62
Neurological diseases as primary gliopathies: a reassessment of neurocentrism. ASN Neuro (2012) 1.50
Alexander disease. J Neurosci (2012) 1.30
Infantile Alexander disease: spectrum of GFAP mutations and genotype-phenotype correlation. Am J Hum Genet (2001) 1.30
A comparison of spinal Iba1 and GFAP expression in rodent models of acute and chronic pain. Brain Res (2008) 1.26
Suppression of GFAP toxicity by alphaB-crystallin in mouse models of Alexander disease. Hum Mol Genet (2009) 1.14
The clinical spectrum of late-onset Alexander disease: a systematic literature review. J Neurol (2010) 1.11
Adult-onset Alexander disease with typical "tadpole" brainstem atrophy and unusual bilateral basal ganglia involvement: a case report and review of the literature. BMC Neurol (2010) 1.07
Reduction of astrogliosis by early treatment of pneumococcal meningitis measured by simultaneous imaging, in vivo, of the pathogen and host response. Infect Immun (2005) 1.05
Properties of astrocytes cultured from GFAP over-expressing and GFAP mutant mice. Exp Cell Res (2008) 1.01
Overcoming functional redundancy to elicit pachyonychia congenita-like nail lesions in transgenic mice. Mol Cell Biol (2005) 0.99
Strategies for treatment in Alexander disease. Neurotherapeutics (2010) 0.98
Astrogliosis. Cold Spring Harb Perspect Biol (2014) 0.97
Formation of GFAP cytoplasmic inclusions in astrocytes and their disaggregation by alphaB-crystallin. Am J Pathol (1999) 0.97
Astrocyte heterogeneity in the brain: from development to disease. Front Cell Neurosci (2015) 0.97
GFAP expression as an indicator of disease severity in mouse models of Alexander disease. ASN Neuro (2013) 0.96
Phenotypic conversions of "protoplasmic" to "reactive" astrocytes in Alexander disease. J Neurosci (2013) 0.96
The impact of glial activation in the aging brain. Aging Dis (2010) 0.95
Adult-onset Alexander disease : report on a family. J Neurol (2007) 0.93
Proliferative reactive gliosis is compatible with glial metabolic support and neuronal function. BMC Neurosci (2011) 0.93
Transcriptional repression and cell death induced by nuclear aggregates of non-polyglutamine protein. Neurobiol Dis (2005) 0.93
Protection against human immunodeficiency virus type 1 Tat neurotoxicity by Ginkgo biloba extract EGb 761 involving glial fibrillary acidic protein. Am J Pathol (2007) 0.92
Protein misfolding and oxidative stress promote glial-mediated neurodegeneration in an Alexander disease model. J Neurosci (2011) 0.92
Protein changes in immunodepleted cerebrospinal fluid from a transgenic mouse model of Alexander disease detected using mass spectrometry. J Proteome Res (2013) 0.88
Alexander disease causing mutations in the C-terminal domain of GFAP are deleterious both to assembly and network formation with the potential to both activate caspase 3 and decrease cell viability. Exp Cell Res (2011) 0.87
Role of GFAP in CNS injuries. Neurosci Lett (2014) 0.86
Alteration of glial-neuronal metabolic interactions in a mouse model of Alexander disease. Glia (2010) 0.85
Astrocytic TDP-43 pathology in Alexander disease. J Neurosci (2014) 0.85
Astrocytes are central in the pathomechanisms of vanishing white matter. J Clin Invest (2016) 0.82
ASTROCYTES: EMERGING STARS IN LEUKODYSTROPHY PATHOGENESIS. Transl Neurosci (2013) 0.82
Involvement of p300 in constitutive and HIV-1 Tat-activated expression of glial fibrillary acidic protein in astrocytes. Glia (2010) 0.82
Archetypal and new families with Alexander disease and novel mutations in GFAP. Arch Neurol (2011) 0.82
MRI reveals differential effects of amphetamine exposure on neuroglia in vivo. FASEB J (2012) 0.81
Genetic ablation of Nrf2/antioxidant response pathway in Alexander disease mice reduces hippocampal gliosis but does not impact survival. PLoS One (2012) 0.81
Caspase cleavage of GFAP produces an assembly-compromised proteolytic fragment that promotes filament aggregation. ASN Neuro (2013) 0.80
Composition of Rosenthal Fibers, the Protein Aggregate Hallmark of Alexander Disease. J Proteome Res (2016) 0.80
Ceftriaxone for Alexander's Disease: A Four-Year Follow-Up. JIMD Rep (2012) 0.78
Astrocytes: the missing link in neurologic disease? Semin Pediatr Neurol (2013) 0.77
Elevated GFAP induces astrocyte dysfunction in caudal brain regions: A potential mechanism for hindbrain involved symptoms in type II Alexander disease. Glia (2015) 0.77
CSF and Blood Levels of GFAP in Alexander Disease(1,2,3). eNeuro (2015) 0.77
Inherited and acquired disorders of myelin: The underlying myelin pathology. Exp Neurol (2016) 0.77
An In Vivo Pharmacological Screen Identifies Cholinergic Signaling as a Therapeutic Target in Glial-Based Nervous System Disease. J Neurosci (2016) 0.76
HIV-1 Tat Induces Unfolded Protein Response and Endoplasmic Reticulum Stress in Astrocytes and Causes Neurotoxicity through Glial Fibrillary Acidic Protein (GFAP) Activation and Aggregation. J Biol Chem (2016) 0.76
Nitric oxide mediates glial-induced neurodegeneration in Alexander disease. Nat Commun (2015) 0.76
Functional characterization of a GFAP variant of uncertain significance in an Alexander disease case within the setting of an individualized medicine clinic. Clin Case Rep (2016) 0.76
The origin of Rosenthal fibers and their contributions to astrocyte pathology in Alexander disease. Acta Neuropathol Commun (2017) 0.75
The role of gigaxonin in the degradation of the glial-specific intermediate filament protein GFAP. Mol Biol Cell (2016) 0.75
Glial fibrillary acidic protein exhibits altered turnover kinetics in a mouse model of Alexander disease. J Biol Chem (2017) 0.75
Effects of traumatic brain injury on reactive astrogliosis and seizures in mouse models of Alexander disease. Brain Res (2014) 0.75
Lithium Decreases Glial Fibrillary Acidic Protein in a Mouse Model of Alexander Disease. PLoS One (2015) 0.75
Alexander Disease Mutations Produce Cells with Coexpression of Glial Fibrillary Acidic Protein and NG2 in Neurosphere Cultures and Inhibit Differentiation into Mature Oligodendrocytes. Front Neurol (2017) 0.75
Characterization of a panel of monoclonal antibodies recognizing specific epitopes on GFAP. PLoS One (2017) 0.75
Astrocyte heterogeneity across the brain and spinal cord occurs developmentally, in adulthood and in response to demyelination. PLoS One (2017) 0.75
Molecular profile of reactive astrocytes--implications for their role in neurologic disease. Neuroscience (1993) 3.51
Alpha B-crystallin is expressed in non-lenticular tissues and accumulates in Alexander's disease brain. Cell (1989) 2.81
GFAP and astrogliosis. Brain Pathol (1994) 2.79
GFAP promoter directs astrocyte-specific expression in transgenic mice. J Neurosci (1994) 2.77
Pathology and biology of the Lewy body. J Neuropathol Exp Neurol (1993) 1.99
GFAP is necessary for the integrity of CNS white matter architecture and long-term maintenance of myelination. Neuron (1996) 1.91
Deficient cerebellar long-term depression, impaired eyeblink conditioning, and normal motor coordination in GFAP mutant mice. Neuron (1996) 1.67
Mice lacking glial fibrillary acidic protein display astrocytes devoid of intermediate filaments but develop and reproduce normally. EMBO J (1995) 1.62
Mice devoid of the glial fibrillary acidic protein develop normally and are susceptible to scrapie prions. Neuron (1995) 1.57
Targeted deletion in astrocyte intermediate filament (Gfap) alters neuronal physiology. Proc Natl Acad Sci U S A (1996) 1.54
Suppression by antisense mRNA demonstrates a requirement for the glial fibrillary acidic protein in the formation of stable astrocytic processes in response to neurons. J Cell Biol (1991) 1.41
Overexpression and abnormal modification of the stress proteins alpha B-crystallin and HSP27 in Alexander disease. Am J Pathol (1993) 1.20
Synthesis and turnover of cytoskeletal proteins in cultured astrocytes. J Neurochem (1984) 1.19
Alpha B-crystallin and 27-kd heat shock protein are regulated by stress conditions in the central nervous system and accumulate in Rosenthal fibers. Am J Pathol (1993) 1.14
GFAP Transgenic Mice Methods (1996) 1.13
Quantification of glial fibrillary acidic protein: comparison of slot-immunobinding assays with a novel sandwich ELISA. Neurotoxicol Teratol (1991) 1.12
Structure and transcriptional regulation of the GFAP gene. Brain Pathol (1994) 1.09
Rosenthal fibers contain ubiquitinated alpha B-crystallin. Am J Pathol (1991) 1.05
Transfection of human astrocytoma cells with glial fibrillary acidic protein complementary DNA: analysis of expression, proliferation, and tumorigenicity. Cancer Res (1993) 1.04
Mallory body-like inclusions in a hereditary congenital neuromuscular disease. Muscle Nerve (1983) 1.04
Change of cytokeratin organization during development of Mallory bodies as revealed by a monoclonal antibody. Lab Invest (1986) 1.00
Characterization of human cDNA and genomic clones for glial fibrillary acidic protein. Brain Res Mol Brain Res (1990) 0.98
Transcription regulation of alpha B-crystallin in astrocytes: analysis of HSF and AP1 activation by different types of physiological stress. J Cell Sci (1996) 0.92
Reexpression of glial fibrillary acidic protein rescues the ability of astrocytoma cells to form processes in response to neurons. J Cell Biol (1994) 0.91
Increment of alpha B-crystallin mRNA in the brain of patient with infantile type Alexander's disease. Biochem Biophys Res Commun (1991) 0.91
Site-specific phosphorylation of the middle molecular weight human neurofilament protein in transfected non-neuronal cells. J Neurosci (1990) 0.91
Loss of Cdk4 expression causes insulin-deficient diabetes and Cdk4 activation results in beta-islet cell hyperplasia. Nat Genet (1999) 8.53
Protection against fatal Sindbis virus encephalitis by beclin, a novel Bcl-2-interacting protein. J Virol (1998) 7.41
hGFAP-cre transgenic mice for manipulation of glial and neuronal function in vivo. Genesis (2001) 6.29
Mutations in GFAP, encoding glial fibrillary acidic protein, are associated with Alexander disease. Nat Genet (2001) 4.63
The cardiovascular response of normal humans to the administration of endotoxin. N Engl J Med (1989) 4.24
Predicting susceptibility and incubation time of human-to-human transmission of vCJD. Lancet Neurol (2006) 3.29
Solar forcing of drought frequency in the Maya lowlands. Science (2001) 3.03
Both oligodendrocytes and astrocytes develop from progenitors in the subventricular zone of postnatal rat forebrain. Neuron (1993) 2.97
Endogenous progenitors remyelinate demyelinated axons in the adult CNS. Neuron (1997) 2.93
Alpha B-crystallin is expressed in non-lenticular tissues and accumulates in Alexander's disease brain. Cell (1989) 2.81
Lewy bodies of Parkinson's disease contain neurofilament antigens. Science (1983) 2.70
Genetic influence on the structural variations of the abnormal prion protein. Proc Natl Acad Sci U S A (2000) 2.46
Climate change as the dominant control on glacial-interglacial variations in C3 and C4 plant abundance. Science (2001) 2.46
A prospective, randomized, controlled trial of prednisone for dilated cardiomyopathy. N Engl J Med (1989) 2.45
Bc1-2 protects mice against fatal alphavirus encephalitis. Proc Natl Acad Sci U S A (1996) 2.31
Histidine regulation in Salmonella typhimurium. IX. Histidine transfer ribonucleic acid of the regulatory mutants. J Biol Chem (1972) 2.04
Ultrasound guidance improves the success rate of internal jugular vein cannulation. A prospective, randomized trial. Chest (1990) 2.02
Elastin degradation in the superficial temporal arteries of patients with intracranial aneurysms reflects changes in plasma elastase. Neurosurgery (1997) 1.98
Suppression of protein synthesis in brain during hibernation involves inhibition of protein initiation and elongation. Proc Natl Acad Sci U S A (1998) 1.91
Cellular distribution of alpha B-crystallin in non-lenticular tissues. J Histochem Cytochem (1990) 1.88
Mayan urbanism: impact on a tropical karst environment. Science (1979) 1.81
Pathological correlates of extrapyramidal signs in Alzheimer's disease. Ann Neurol (1997) 1.78
Isolation and characterization of glial filaments from human brain. J Cell Biol (1978) 1.74
GFAP mutations, age at onset, and clinical subtypes in Alexander disease. Neurology (2011) 1.69
Intrasomatic injection of radioactive precursors for studying transmitter synthesis in identified neurons of Aplysia californica. Proc Natl Acad Sci U S A (1973) 1.66
What are melanocytes really doing all day long...? Exp Dermatol (2009) 1.65
Combined chemokine and cytokine gene transfer enhances antitumor immunity. Nat Med (1996) 1.61
Frequency-domain photon migration measurements of normal and malignant tissue optical properties in a human subject. Appl Opt (1997) 1.60
The migrational patterns and developmental fates of glial precursors in the rat subventricular zone are temporally regulated. Development (1993) 1.58
Photoreceptor cell death by apoptosis in dogs with sudden acquired retinal degeneration syndrome. Am J Vet Res (1998) 1.57
Molecular findings in symptomatic and pre-symptomatic Alexander disease patients. Neurology (2002) 1.54
Targeted deletion in astrocyte intermediate filament (Gfap) alters neuronal physiology. Proc Natl Acad Sci U S A (1996) 1.54
A downstream initiation element required for efficient TATA box binding and in vitro function of TFIID. Nature (1990) 1.53
Diffuse Lewy body disease. Neuropathological and biochemical studies of six patients. Acta Neuropathol (1987) 1.47
Early patterns of migration, morphogenesis, and intermediate filament expression of subventricular zone cells in the postnatal rat forebrain. J Neurosci (1995) 1.46
Accumulation of alpha B-crystallin in central nervous system glia and neurons in pathologic conditions. Am J Pathol (1992) 1.46
Variant CJD infection in the spleen of a neurologically asymptomatic UK adult patient with haemophilia. Haemophilia (2010) 1.45
Caffeine blocks activation of cyclic AMP synthesis in Dictyostelium discoideum. Dev Biol (1984) 1.43
Efficient infection of primitive hematopoietic stem cells by modified adenovirus. Gene Ther (2001) 1.42
Lipid phase transitions in cytoplasmic and outer membranes of Escherichia coli. Biochim Biophys Acta (1975) 1.42
Rosenthal fibers share epitopes with alpha B-crystallin, glial fibrillary acidic protein, and ubiquitin, but not with vimentin. Immunoelectron microscopy with colloidal gold. Am J Pathol (1991) 1.42
Nonspecific interstitial pneumonitis: a common cause of pulmonary disease in the acquired immunodeficiency syndrome. Ann Intern Med (1987) 1.41
In vitro amplification and detection of variant Creutzfeldt-Jakob disease PrPSc. J Pathol (2007) 1.41
A randomized, prospective trial of stapled lung reduction versus laser bullectomy for diffuse emphysema. J Thorac Cardiovasc Surg (1996) 1.41
Two-dimensional and 3-dimensional optical coherence tomographic imaging of the airway, lung, and pleura. J Thorac Cardiovasc Surg (2005) 1.39
Diffusing capacity limitations of the extent of lung volume reduction surgery in an animal model of emphysema. J Thorac Cardiovasc Surg (1999) 1.39
The effects of heterologous platelet transfusion on pulmonary function during ARDS. Chest (1990) 1.39
Patterns and dynamics of SVZ cell migration in the postnatal forebrain: monitoring living progenitors in slice preparations. Neuron (1999) 1.39
Conditional ablation of cerebellar astrocytes in postnatal transgenic mice. J Neurosci (1996) 1.37
Heterogeneity of cycling glial progenitors in the adult mammalian cortex and white matter. J Neurobiol (2001) 1.36
Cytoskeletal protein abnormalities in neurodegenerative diseases. Ann Neurol (1986) 1.35
Generation of cerebellar interneurons from dividing progenitors in white matter. Neuron (1996) 1.35
Laboratory diagnosis of variant Creutzfeldt-Jakob disease. Histopathology (2000) 1.34
IL-2 adenovector-transduced autologous tumor cells induce antitumor immune responses in patients with neuroblastoma. Blood (1998) 1.33
Glial inclusions in CNS degenerative diseases. J Neuropathol Exp Neurol (1996) 1.32
Is lobectomy by video-assisted thoracic surgery an adequate cancer operation? Ann Thorac Surg (1998) 1.30
Infantile Alexander disease: spectrum of GFAP mutations and genotype-phenotype correlation. Am J Hum Genet (2001) 1.30
Specificity of lymphoreticular accumulation of prion protein for variant Creutzfeldt-Jakob disease. J Clin Pathol (2004) 1.26
Multiple interacting sites regulate astrocyte-specific transcription of the human gene for glial fibrillary acidic protein. J Biol Chem (1991) 1.26
A clinicopathological comparison of community-based and clinic-based cohorts of patients with dementia. Arch Neurol (1999) 1.25
PDGF stimulates the massive expansion of glial progenitors in the neonatal forebrain. Glia (2009) 1.24
Use of the Heimlich valve to shorten hospital stay after lung reduction surgery for emphysema. Ann Thorac Surg (1996) 1.23
Cycling cells in the adult rat neocortex preferentially generate oligodendroglia. J Neurosci Res (1999) 1.23
A study of infantile motor neuron disease with neurofilament and ubiquitin immunocytochemistry. Neuropediatrics (1989) 1.21
The association of actin with Hirano bodies. J Neuropathol Exp Neurol (1983) 1.20
Overexpression and abnormal modification of the stress proteins alpha B-crystallin and HSP27 in Alexander disease. Am J Pathol (1993) 1.20
Synthesis and turnover of cytoskeletal proteins in cultured astrocytes. J Neurochem (1984) 1.19
Alterations in amounts and rates of serotonin transported in an axon of the giant cerebral neurone of Aplysia californica. J Physiol (1976) 1.16
Alpha B-crystallin and 27-kd heat shock protein are regulated by stress conditions in the central nervous system and accumulate in Rosenthal fibers. Am J Pathol (1993) 1.14
A2B5+ and O4+ Cycling progenitors in the adult forebrain white matter respond differentially to PDGF-AA, FGF-2, and IGF-1. Mol Cell Neurosci (2002) 1.14
Pathologic findings on re-excision of the primary site in breast cancer patients considered for treatment by primary radiation therapy. Cancer (1987) 1.13
Axonal transport of newly synthesized glycoproteins in a single identified neuron of Aplysia californica. J Cell Biol (1974) 1.13
Histidine regulation in salmonella typhimurium. XIV. Interaction of the histidyl transfer ribonucleic acid synthetase with histidine transfer ribonucleic acid. J Biol Chem (1972) 1.11
Growth kinetics, cell shape, and the cytoskeleton of primary astrocyte cultures. J Neurochem (1984) 1.10
Should lung volume reduction for emphysema be unilateral or bilateral? J Thorac Cardiovasc Surg (1996) 1.10
A case of protease sensitive prionopathy in a patient in the UK. Neuropathol Appl Neurobiol (2009) 1.10
In Vitro and In Vivo Antitumor Effect of Anti-CD33 Chimeric Receptor-Expressing EBV-CTL against CD33 Acute Myeloid Leukemia. Adv Hematol (2012) 1.09
Directed establishment of rat brain cell lines with the phenotypic characteristics of type 1 astrocytes. Proc Natl Acad Sci U S A (1992) 1.09
Neuropathology and molecular biology of variant Creutzfeldt-Jakob disease. Curr Top Microbiol Immunol (2004) 1.08
Axonal transport of [3H]serotonin in an identified neuron of Aplysia californica. J Cell Biol (1976) 1.08
Interactions between glial progenitors and blood vessels during early postnatal corticogenesis: blood vessel contact represents an early stage of astrocyte differentiation. J Comp Neurol (1997) 1.07
Thoracoscopic carbon dioxide laser treatment of bullous emphysema. Lancet (1991) 1.07
Lung function 5 yr after lung volume reduction surgery for emphysema. Am J Respir Crit Care Med (2001) 1.06
Alterations in calcium content and biochemical processes in cultured skin fibroblasts from aged and Alzheimer donors. Proc Natl Acad Sci U S A (1986) 1.06
Multipotential and lineage restricted precursors coexist in the mammalian perinatal subventricular zone. J Neurosci Res (1997) 1.05
Interleukin-2 gene-modified allogeneic tumor cells for treatment of relapsed neuroblastoma. Hum Gene Ther (1998) 1.04
The first case of protease-sensitive prionopathy (PSPr) in The Netherlands: a patient with an unusual GSS-like clinical phenotype. J Neurol Neurosurg Psychiatry (2010) 1.04
Gliogenesis in rat spinal cord: evidence for origin of astrocytes and oligodendrocytes from radial precursors. J Neurosci Res (1989) 1.04
Cellular specificity of serotonin storage and axonal transport in identified neurones of Aplysia californica. J Physiol (1974) 1.03
The AB-variant of GM2-gangliosidosis. Clinical, biochemical, and pathological studies of two patients. Acta Neuropathol (1980) 1.03
Mutations affecting N-acetylglucosaminidase in Dictyostelium discoideum. Proc Natl Acad Sci U S A (1973) 1.03
Preferential expression of alpha B-crystallin in astrocytic elements of neuroectodermal tumors. Cancer (1991) 1.02
Hemodynamic changes in rat leg muscles during tourniquet-induced ischemia-reperfusion injury observed by near-infrared spectroscopy. Physiol Meas (2009) 1.02
High susceptibility to cerebral ischemia in GFAP-null mice. J Cereb Blood Flow Metab (2000) 1.02
Synthesis of glycoproteins in a single identified neuron of Aplysia californica. J Cell Biol (1974) 1.01
Techniques for rapid biochemical screening of large numbers of cell clones. Exp Cell Res (1975) 1.01
Patient selection criteria for lung volume reduction surgery. J Thorac Cardiovasc Surg (1997) 1.00
Resistance of interleukin-1beta-deficient mice to fatal Sindbis virus encephalitis. J Virol (1999) 1.00
Small heat shock proteins, the cytoskeleton, and inclusion body formation. Neuropathol Appl Neurobiol (2000) 1.00